Section Arrow
Quote
EVO.NASDAQ
- Evotec SE
Quotes are at least 15-min delayed:2025/11/07 08:41 EST
Pre Market
Last
 3.1
-0.205 (-6.20%)
Bid
3.08
Ask
3.1
High 3.3 
Low 3.1 
Volume 6503 
Regular Hours
Last
 3.305
-0.04 (-1.20%)
Day High 
3.37 
Prev. Close
3.345 
1-M High
4.27 
Volume 
51.46K 
Bid
3.08
Ask
3.1
Day Low
3.3 
Open
3.35 
1-M Low
3.3 
Market Cap 
1.19B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 4 
20-SMA 3.97 
50-SMA 3.76 
52-W High 5.6405 
52-W Low 2.84 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.44/-0.09
Enterprise Value
1.58B
Balance Sheet
Book Value Per Share
2.74
Cash Flow
Cash Flow Yield
0.11
Income Statement
Total Revenue
796.97M
Operating Revenue Per Share
2.45
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health41.52-2.21-5.05%83.3PE
Pre Market 40.64 -0.88 -2.12%
TLRYTilray Brands1.21-0.07-5.47%-- 
Pre Market 1.21 0 0.00%
TEVATeva Pharmaceutical Industries Limited24.46-0.14-0.57%-- 
Pre Market 24.15 -0.31 -1.27%
CGCCanopy Growth Corp1.09-0.05-4.39%-- 
Pre Market 1.29 +0.2 +18.35%
VTRSViatris10.11-0.64-5.95%227.2PE
Pre Market 10.1 -0.01 -0.10%
Quotes are at least 15-min delayed：2025/11/07 08:41 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000employees and 18 production sites mainly in Europe and the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.